DBM-MMAF Catalog No.:M26119-C 18-hexahydroxy-16-[(Z)-{1-hydroxy-2-[(Z)-(1-hydroxyethylidene)amino]hexylidene}amino]-3-[(1H-indol-3-yl)methyl]-9-[(naphthalen-2-yl)methyl]-1

18-hexahydroxy-16-[(Z)-{1-hydroxy-2-[(Z)-(1-hydroxyethylidene)amino]hexylidene}amino]-3-[(1H-indol-3-yl)methyl]-9-[(naphthalen-2-yl)methyl]-1

A novel Wnt pathway inhibitor

InChi: InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4

Endurobol was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases

Formula: C17H27ClN2O4S

DBM-MMAF Catalog No.:M26119-C 18-hexahydroxy-16-[(Z)-{1-hydroxy-2-[(Z)-(1-hydroxyethylidene)amino]hexylidene}amino]-3-[(1H-indol-3-yl)methyl]-9-[(naphthalen-2-yl)methyl]-1DBM MMAF is a drug linker conjugate composed of a potent antitubulin agent MMAF and a linker DBM to make antibody drug conjugate (ADC). Product information CAS Number: 1810001 93 4 Molecular Weight: 1082. 95 Formula: C49H74Br2N6O11 Chemical Name: (2S) 2 [(2R) 2 [(R) [(2S) 1 [(3R,4S,5S) 4 [(2S) 2 [(2S) 2 [6 (3,4 dibromo 2,5 dioxo 2,5 dihydro 1H pyrrol 1 yl) N methylhexanamido] 3 methylbutanamido] N,3 dimethylbutanamido] 3 methoxy 5